Novavax CEO Stanley Erck's 2020 pay jumps 1,872% to $48M
Novavax reports 2020 executive compensation
By ExecPay News
Published: May 3, 2021
Novavax reported fiscal year 2020 executive compensation information on May 3, 2021.
In 2020, five Novavax executives received on average a compensation package of $23M, a 1,205% increase compared to previous year.
Average pay of disclosed executives at Novavax
Stanley C. Erck, Chief Executive Officer, received $48M in total, which increased by 1,872% compared to 2019. 92% of Erck's compensation, or $44M, was in option awards. Erck also received $591K in non-equity incentive plan, $657K in salary, $2.7M in stock awards, as well as $11K in other compensation.
For fiscal year 2020, the median employee pay was $400,755 at Novavax. Therefore, the ratio of Stanley C. Erck's pay to the median employee pay was 120 to one.
Gregory M. Glenn, President, Research and Development, received a compensation package of $25M, which increased by 1229% compared to previous year. 92% of the compensation package, or $23M, was in option awards.
John J. Trizzino, Chief Financial Officer, earned $21M in 2020, a 1355% increase compared to previous year.
John A. Herrmann III, Chief Legal Officer, received $21M in 2020, which increases by 1423% compared to 2019.
Gregory F. Covino, Chief Financial Officer, earned $1.4M in 2020.
Related executives
You may also like
Source: SEC filing on May 3, 2021.